Decoy Therapeutics is trading 5.23% down at $2.90 after no clear company-specific announcement, filing, earnings release, or major event was identified for September 2, 2026.

  • Recent indexed company items include earlier financing and pipeline updates, neither of which directly explains the pre-market decline.
  • Broader futures are modestly lower amid risk-off geopolitical sentiment, but the move is not strong enough to establish a clear cause.